Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Melanoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 79 Leukemia 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Lymphoma 24 Leukemia, Erythroblastic, Acute 15 Leukemia, Myelomonocytic, Acute 14 Leukemia, Monocytic, Acute 14 Leukemia, Megakaryoblastic, Acute 14 Burkitt Lymphoma 12 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Non-Hodgkin 9 Congenital Abnormalities 9 Myelodysplastic Syndromes 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Anemia, Refractory, with Excess of Blasts 7 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Chronic-Phase 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, Follicular 5 Hodgkin Disease 5 Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Multiple Myeloma 4 Lymphoma, Large-Cell, Immunoblastic 4 Leukemia, Promyelocytic, Acute 4 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4 Leukemia, Eosinophilic, Acute 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large-Cell, Anaplastic 3

Interventions

Dacarbazine 24 Nivolumab 20 pembrolizumab 17 Ipilimumab 15 Interferon-alpha 10 trametinib 8 dabrafenib 7 aldesleukin 7 Vemurafenib 7 Temozolomide 7 Introns 6 Interferon alpha-2 6 Interleukin-2 5 Cisplatin 5 binimetinib 4 Radiotherapy 4 Chemotherapy, Adjuvant 4 encorafenib 3 cobimetinib 3 cemiplimab 3 Vinblastine 3 Specimen Handling 3 Sodium Chloride 3 Radiosurgery 3 Paclitaxel 3 Opdualag 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 CTLA-4 Antigen 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡